Xenadrine Reviews
Summary
Xenadrine is a supplement business that sells four products, including Core Hardcore Thermogenic, Maximum Hardcore Xenadrine Ripped, Powerful and Ultimate. RiskScore has not tested its products yet. The FDA has received 18 adverse event reports submitted to the FDA covering the years 2004 to 2018.
Public safety signals
18 adverse event reports in public records.
- Adverse eventSource: openFDA
Adverse event report: Cardiac failure, Cardiomyopathy
Product: XENADRINE. Outcome: Life Threatening, Hospitalization, Disability, Visited a Health Care Provider. Reactions: Cardiac failure, Cardiomyopathy. FDA CAERS report 2018-CFS-003589.
- Adverse eventSource: openFDA
Adverse event report: Heart rate increased, Insomnia, Supraventricular tachycardia
Product: XENADRINE CAPSULES (DIETARY SUPPLEMENT) CAPSULE. Outcome: Other Serious or Important Medical Event, Visited Emergency Room. Reactions: Heart rate increased, Insomnia, Supraventricular tachycardia. FDA CAERS report 184660.
- Adverse eventSource: openFDA
Adverse event report: Diarrhoea, Hepatic enzyme increased, Skin odour abnormal
Product: XENADRINE CAPSULES DIETARY SUPPLEMENT CAPSULE. Outcome: Other Serious or Important Medical Event, Visited a Health Care Provider. Reactions: Diarrhoea, Hepatic enzyme increased, Skin odour abnormal. FDA CAERS report 181547.
- Adverse eventSource: openFDA
Adverse event report: Fibrocystic breast disease
Product: XENADRINE CAPSULES. Outcome: Other Serious or Important Medical Event. Reactions: Fibrocystic breast disease. FDA CAERS report 172593.
- Adverse eventSource: openFDA
Adverse event report: Abdominal pain, Chromaturia, Decreased appetite and 6 more
Product: XENADRINE. Outcome: Hospitalization, Other Serious or Important Medical Event, Visited Emergency Room, Visited a Health Care Provider. Reactions: Abdominal pain, Chromaturia, Decreased appetite, Fatigue, Hepatitis a, Liver function test abnormal, Nausea, Pruritus, Vomiting. FDA CAERS report 150602.
- Adverse eventSource: openFDA
Adverse event report: Diarrhoea, Headache, Pain and 4 more
Product: XENADRINE ULTRA. Outcome: Other Serious or Important Medical Event. Reactions: Diarrhoea, Headache, Pain, Psychomotor skills impaired, Speech disorder, Visual acuity reduced, Vomiting. FDA CAERS report 128938.
- Adverse eventSource: openFDA
Adverse event report: Headache, Subarachnoid haemorrhage
Product: XENADRINE. Outcome: Life Threatening, Hospitalization, Visited Emergency Room. Reactions: Headache, Subarachnoid haemorrhage. FDA CAERS report 128539.
- Adverse eventSource: openFDA
Adverse event report: Headache
Product: XENADRINE ULTRA RAPID RELEASE. Outcome: Other Serious or Important Medical Event, Visited Emergency Room. Reactions: Headache. FDA CAERS report 124339.
- Adverse eventSource: openFDA
Adverse event report: Hepatic enzyme increased, Jaundice, Liver injury and 1 more
Product: XENADRINE. Outcome: Hospitalization. Reactions: Hepatic enzyme increased, Jaundice, Liver injury, Malaise. FDA CAERS report 118518.
- Adverse eventSource: openFDA
Adverse event report: Asthenia, Dyspnoea, Fatigue and 3 more
Product: XENADRINE. Outcome: Life Threatening, Disability, Other Serious or Important Medical Event. Reactions: Asthenia, Dyspnoea, Fatigue, Irritability, Pain, Tremor. FDA CAERS report 90080.
Show 8 more
- Adverse eventSource: openFDA
Adverse event report: Chest discomfort, Dyspnoea
Product: XENADRINE. Outcome: Hospitalization. Reactions: Chest discomfort, Dyspnoea. FDA CAERS report 86368.
- Adverse eventSource: openFDA
Adverse event report: Death, Pulse absent, Respiratory arrest
Product: XENADRINE. Outcome: Death, Visited Emergency Room. Reactions: Death, Pulse absent, Respiratory arrest. FDA CAERS report 71305.
- Adverse eventSource: openFDA
Adverse event report: Convulsion, Emergency care examination, Physical examination
Product: XENADRINE. Outcome: Hospitalization, Visited a Health Care Provider. Reactions: Convulsion, Emergency care examination, Physical examination. FDA CAERS report 71275.
- Adverse eventSource: openFDA
Adverse event report: Hemiparesis, Hospitalisation, Paraesthesia
Product: XENADRINE. Outcome: Hospitalization. Reactions: Hemiparesis, Hospitalisation, Paraesthesia. FDA CAERS report 70056.
- Adverse eventSource: openFDA
Adverse event report: Asthenia, Asthma, Disorientation and 6 more
Product: XENADRINE. Outcome: Life Threatening, Visited Emergency Room, Visited a Health Care Provider. Reactions: Asthenia, Asthma, Disorientation, Emergency care examination, Headache, Hypertension, Respiratory arrest, Rhinitis, Weight decreased. FDA CAERS report 66814.
- Adverse eventSource: openFDA
Adverse event report: Abdominal pain, Alanine aminotransferase increased, Aspartate aminotransferase increased and 2 more
Product: XENADRINE. Outcome: Hospitalization. Reactions: Abdominal pain, Alanine aminotransferase increased, Aspartate aminotransferase increased, Cholelithiasis obstructive, Jaundice. FDA CAERS report 66169.
- Adverse eventSource: openFDA
Adverse event report: Blood potassium decreased, Chest pain, Dyspnoea and 4 more
Product: XENADRINE. Outcome: Life Threatening, Hospitalization, Required Intervention, Visited Emergency Room. Reactions: Blood potassium decreased, Chest pain, Dyspnoea, Fatigue, Hospitalisation, Myocardial infarction, Palpitations. FDA CAERS report 65679.
- Adverse eventSource: openFDA
Adverse event report: Headache, Pain, Tenderness
Product: XENADRINE. Outcome: Other Outcome. Reactions: Headache, Pain, Tenderness. FDA CAERS report 65433.
Products
4 products listed for Xenadrine.
| Product | Rating |
|---|---|
| Core Hardcore Thermogenic | Not tested yet |
| Maximum Hardcore Xenadrine Ripped | Not tested yet |
| Powerful | Not tested yet |
| Ultimate | Not tested yet |
Lab tests
Reviews
No reviews yet.